Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Demyelinating and inflammatory diseases of the central nervous system (CNS) are varied and often enigmatic. Multiple sclerosis ( MS), the prototypical inflammatory demyelinating disease, is a chronic autoimmune disorder characterized by loss of myelin and relative preservation of axons. Acute disseminated encephalomyelitis (ADEM) is a monophasic illness that is pathologically similar to MS but is typically triggered by an antecedent viral infection. Central pontine myelinolysis (CPM) refers to osmotic demyelination in the setting of rapid correction of hyponatremia. Sarcoidosis and Behçet disease are idiopathic systemic inflammatory diseases that may involve the CNS. Dysmyelinating diseases, such as Alexander and Canavan diseases, are genetic disorders in which there is an intrinsic abnormality of myelin; they present in childhood and will not be discussed in this chapter.
The hallmark of MS is episodic or progressive multifocal deficits affecting the CNS in otherwise healthy young adults. The most common initial clinical manifestations of MS are sensory disturbances, visual loss, and weakness. Diagnosis relies on recognition of the clinical patterns of disease and is supported by magnetic resonance imaging (MRI) studies of the brain and spinal cord, and analysis of cerebrospinal fluid (CSF; in those with a progressive onset). Systemic illnesses that can mimic the symptoms of MS must be excluded.
Next to trauma, MS is the most common cause of disability in young adults. MS affects approximately 350,000 to 500,000 Americans and more than 1 million individuals worldwide. The cause of MS is unknown, and because there is no single diagnostic test, accurate diagnosis relies on clinical recognition of the disease. The hallmarks of MS are multifocal waxing and waning, or progressive neurologic deficits, that localize to the CNS. The signs and symptoms of MS are separated in space (multiple areas of the CNS) and evolve over time (during the life of the patient). MS affects only the CNS and spares the peripheral nerves.
MS has a distinct pathology characterized by focal demyelination within the brain and spinal cord. MS is considered an autoimmune disease because inflammatory infiltrates are present within the damaged myelin. However, it is not known whether the immune response is a primary process or is triggered by infectious, toxic, or metabolic etiologies. There is no cure for MS, and current treatments are only partially effective, although tremendous progress has been made, particularly in relapsing forms of the illness.
MS affects women two to three times as often as men. MS is rare in the pediatric population, but its risk increases steadily from adolescence up to the age of 35, then gradually decreases, and is rarely diagnosed after the age of 65. MS is uncommon in equatorial climates, and its prevalence increases with northern distance from the equator.
The risk of MS is much higher in populations of Northern European ancestry than in other ethnic groups residing at the same latitudes. Twin studies demonstrate concordance rates of approximately 30% in identical twins and 5% in fraternal twins. The rate for first-degree relatives of MS patients also is 5%. Genome-wide association studies have identified over 100 risk alleles for MS. These alleles provide clues to pathophysiology and potential therapeutic targets.
The term multiple sclerosis refers to discrete hard or rubbery plaques within the white matter of the brain and spinal cord. These lesions are composed of areas of myelin and oligodendrocyte loss accompanied by infiltrates of macrophages and lymphocytes. The focal loss of myelin indicates a highly specific demyelinating process and distinguishes MS from leukodystrophies. In addition, preserved axons and neurons discern MS from other destructive processes. Although axons in MS plaques are relatively spared, axonal transection occurs, is irreversible, and presumably leads to neuronal death by Wallerian degeneration.
The initial focal manifestations may be acute or insidious and can vary in severity. Acute neurologic deficits caused by MS are called relapses and are known as flares, attacks, or exacerbations. The most common initial symptoms are sensory disturbances, visual loss, and weakness, although abnormal gait, loss of dexterity, diplopia, ataxia, vertigo, or sphincter disturbances can occur. Nonspecific symptoms such as malaise or fatigue often precede the initial focal disturbance.
The most common presenting symptom of MS is paresthesia (tingling, pins and needles), dysesthesia (burning, gritty, sandy, electrical, or wet sensations), or hypesthesia (loss of sensation or procaine-like numbness). Some patients describe a squeezing sensation as if a limb or the trunk were tightly wrapped. These symptoms can be intermittent or constant and can spread from one location to adjoining areas. Spinal cord involvement is implied by ascending numbness with a sensory level. A Lhermitte symptom, an electrical or shocklike paresthesia that radiates down the spine and into one or more limbs after neck flexion, localizes the lesion to the cervical spine. Sensory disturbances associated with MS flares usually resolve spontaneously but sometimes evolve into chronic neuropathic pain. Trigeminal neuralgia also occurs in MS, perhaps caused by demyelination in the root entry zone of the trigeminal nerve.
The next most common presenting manifestation of MS is optic neuritis, which causes loss of vision affecting usually one eye evolving over hours or days. Bilateral simultaneous optic neuritis is much less frequent and should raise the possibility of an alternate diagnosis such as neuromyelitis optica spectrum disorder (NMOSD). Loss of vision can be complete or partial; patients will often report a scotoma, which is an area of diminished or blurred vision in the monocular field. Optic neuritis is often associated with periorbital pain elicited by eye movements. Loss of vision can be subtle and affect only color vision. Red desaturation, or the inability to distinguish shades of red, can be quantified using Ishihara color plates. Demyelination of the optic nerve close to the retina causes optic disc pallor. The differential diagnosis of acute visual loss is shown in Table 21.1 .
V | Vascular: nonarteritic anterior ischemic optic neuropathy, giant cell arteritis, diabetic retinopathies, Susac syndrome (microangiopathy of the brain, retina, and inner ear), acute posterior multifocal placoid pigment epitheliopathy, Eales disease (noninflammatory occlusive disease of the retinal vasculature), Cogan syndrome (interstitial keratitis, vestibular dysfunction, and deafness), amaurosis fugax, central retinal vein occlusion, aneurysms and arteriovenous malformations, systemic hypercoagulable states including anticardiolipin syndrome |
I | Infectious: rarely cause such rapid visual loss without other symptoms and can be local (retinitis, periostitis, meningitis) or systemic (syphilis, toxoplasmosis, typhoid fever, leptospirosis) |
T | Trauma: rare |
A | Autoimmune: sarcoidosis, optic neuritis |
M | Metabolic /toxic: vitamin B 12 deficiency, toxins (e.g., ethyl alcohol, ethambutol, methanol, amiodarone, clioquinol, chemotherapeutic agents, benzene), tropical ataxic neuropathy (cassava diet, tobacco use associated with a defect in cyanide detoxification), radiation-induced optic neuropathy |
I | Idiopathic/hereditary: Leber hereditary optic neuropathy, Kearns-Sayre syndrome, MELAS, NARP, Friedreich ataxia |
N | Neoplastic/paraneoplastic/infiltrative: infiltrating neoplasms (e.g., lymphoma, leukemia, myeloma, carcinomatous meningitis), optic nerve glioma, optic nerve glioblastoma, optic sheath meningioma, CAR, CACD, MAR, DUMP, PCGN, Langerhans cell disorders |
S | Psychiatric: conversion reaction |
Others: | central serous chorioretinopathy, optic disc drusen, ophthalmic migraine, big blind spot syndromes (acute zonal occult outer retinopathy, acute macular neuroretinopathy, multiple evanescent white dot syndrome, acute idiopathic blind spot enlargement syndrome) |
Motor symptoms are as common as optic neuritis as initial manifestations of MS and include limb weakness, loss of dexterity, and gait disturbance. Symptoms typically evolve over hours or days; sometimes patients will awaken with a motor deficit. Weakness can affect a single limb or cause hemiparesis or paraparesis. The hemiparesis of MS usually spares the face. Sometimes weakness becomes apparent only during exertion. Weakness is usually accompanied by spasticity and hyperreflexia.
Dysconjugate eye movements resulting in diplopia are common in MS. Intranuclear ophthalmoplegia (INO) is caused by demyelinating plaques within the medial longitudinal fasciculus (MLF). Lesions in the MLF typically occur ipsilateral to the affected third nucleus and result in impaired ipsilateral adduction with compensatory nystagmus of the abducting eye. MS also can cause vertical diplopia and isolated impairments of the sixth, third, and fourth nerves.
Dyscoordinated movements of the limbs or trunk are common in MS because of plaques affecting the cerebellar afferent or efferent pathways and range in severity from subtle to disabling. Tremor and dysmetria, an error in measurement of movement, are often observed on finger-nose-finger and heel-knee-shin tests. Dysrhythmia can be demonstrated by finger or toe tapping. Romberg sign, truncal swaying on standing with the feet together and eyes closed, can be caused by impaired proprioception from spinal cord dorsal column lesions.
Cognitive impairments are present in 40% to 65% of MS patients and can result in loss of vocation and impairment of activities of daily living. Patients often report difficulties with short-term memory, attention, information processing, problem-solving, multitasking, and language function. Cognitive deficits may not be detected by the Mini-Mental Status Examination and often require neuropsychiatric testing. Emotional lability is common; up to 60% of MS patients suffer from depression.
Patients often complain of urinary urgency, frequency, hesitancy, and incontinence. Incontinence can occur in the setting of a spastic bladder that is incapable of filling completely or with a distended (denervated) bladder that overflows. It is often not possible to determine the nature of bladder dysfunction by history. Measurement of the volume of postvoid residual urine, by catheterization, ultrasound, or urodynamic studies, is essential for distinguishing between a spastic and denervated bladder. Bladder dyssynergia, an impairment of sphincter and detrusor coordination, also is a cause of hesitancy and incomplete voiding. Patients with urinary retention are susceptible to urinary tract infections, and such infections may trigger MS relapses by stimulating the immune system.
Bowel dysfunction is common in MS and is presumably caused by spinal cord plaques. Chronic constipation can worsen spasticity. Incontinence occurs either as a consequence of sphincter dysfunction or from bowel spasticity and fecal urgency.
Vertigo caused by MS is sometimes associated with other signs or symptoms of brain stem pathology such as facial sensory loss or diplopia. Vertigo can be fleeting or last for days or even weeks. Although uncommon, unilateral hearing loss occurs in MS, sometimes in conjunction with vertigo. Vertigo caused by labyrinthine pathology identified by the Dix-Hallpike maneuver (see Chapter 14 ) is not caused by MS.
Impairments of speech are common in MS and can be caused by tongue weakness from lower brain stem dysfunction, spastic dysarthria from corticobulbar injury, or scanning dysarthria from cerebellar dysfunction.
Impairment of swallowing occurs in MS, particularly later in the course of the disease. Choking on thin liquids is consistent with neurologic injury as opposed to solid food dysphagia, which is typically caused by a pharyngeal structural abnormality. Barium swallow and fiberscope endoscopic evaluation of swallowing are helpful in assessing aspiration risk.
Lower motor neuron facial weakness, similar to Bell palsy, can occur when MS plaques affect intraparenchymal emerging fibers of the seventh cranial nerve. Ipsilateral loss of taste, hyperacusis, retroauricular pain, and synkinesis are hallmarks of peripheral facial neuropathy and do not occur with central facial weakness. Facial myokymia is a chronic flickering contraction of the orbicularis oculi or other muscles of facial expression caused by injury to the facial nerve or corticobulbar tracts within the brain stem.
Fatigue is the most common symptom of MS and contends with cognitive impairment as the major cause of loss of vocation. Fatigue can occur as a consequence of exertion (neuromuscular weakness), as a manifestation of depression, as a consequence of insomnia (daytime drowsiness), or as a generalized lassitude. Fatigue is often worse in the afternoon but can be present on awakening and persist throughout the day.
Virtually all symptoms of MS, including the Lhermitte symptom, sensory disturbances, weakness, ataxia, vertigo, and diplopia, can occur as transient paroxysms lasting for seconds to minutes, sometimes in clusters. Flexor spasms are brief tonic spasms of a limb or the face and often occur at night and in clusters. Flexor spasms are frequently preceded by paresthesias and can be elicited by movements, hyperventilation, or other precipitating factors.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here